Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic.
Elizabeth Lerner PapautskyTamara HamlishPublished in: Breast cancer research and treatment (2020)
Our findings reveal a pervasive impact of COVID-19 on breast cancer care and a gap in disaster preparedness that leaves cancer survivors at risk for poor outcomes. Delays are critical to capture and characterize to help cancer providers and healthcare systems develop effective and patient-tailored processes and strategies to manage cases during the current pandemic wave, subsequent waves, and future disasters.
Keyphrases
- healthcare
- patient reported
- coronavirus disease
- sars cov
- childhood cancer
- papillary thyroid
- public health
- palliative care
- young adults
- case report
- squamous cell
- respiratory syndrome coronavirus
- current status
- single cell
- squamous cell carcinoma
- genome wide
- quality improvement
- type diabetes
- gene expression
- social media
- affordable care act
- weight loss
- lymph node metastasis
- health information
- health insurance